CRISPR: a revolutionary tool for modeling and treating cancer and Duchenne muscular dystrophy
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
Κύριος συγγραφέας: | Eva, Israt Ara Jannat |
---|---|
Άλλοι συγγραφείς: | Rahman, Kazi Fatema |
Μορφή: | Thesis |
Γλώσσα: | English |
Έκδοση: |
Brac University
2023
|
Θέματα: | |
Διαθέσιμο Online: | http://hdl.handle.net/10361/17764 |
Παρόμοια τεκμήρια
-
A review on CRISPR-Cas system based applications in Oncology
ανά: Sadia, Mir
Έκδοση: (2022) -
CRISPR/Cas9 system: A versatile gene editing tool in disease prevention and treatment
ανά: Maria, Amatul
Έκδοση: (2020) -
Comparative analysis of CRISPR-Cas systems of Yersinia pestis and Escherichia coli strains. (November 2020 – December 2021)
ανά: Nwabunwanne, Eze Uchenna
Έκδοση: (2022) -
Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
ανά: Shaikat, Mahdi Mubin
Έκδοση: (2023) -
CRISPR/Cas9 genome editing to treat sickle cell disease
ανά: Ullah, Mohammad
Έκδοση: (2023)